A phase Ib study of sEphB4-HSA combined with first-line chemotherapy in patients (pts) with advanced pancreatic (PC) and biliary cancers (BC).

Diana L. Hanna,Syma Iqbal,Diane Habib,Denice D. Tsao-Wei,Afsaneh Barzi,Jacob Stephen Thomas,Victor Chiu,Imran N. Siddiqi,Rishi D. Bhavsar,Nicole G. Jensen,Cristina DeLeon,Heinz-Josef Lenz,Parkash S. Gill,Anthony B. El-Khoueiry

A phase Ib study of sEphB4-HSA combined with first-line chemotherapy in patients (pts) with advanced pancreatic (PC) and biliary cancers (BC).

2020

Diana L. Hanna
Syma Iqbal
Diane Habib
Denice D. Tsao-Wei
Afsaneh Barzi
Jacob Stephen Thomas
Victor Chiu
Imran N. Siddiqi
Rishi D. Bhavsar
Nicole G. Jensen
Cristina DeLeon
Heinz-Josef Lenz
Parkash S. Gill
Anthony B. El-Khoueiry

4640Background: EphB4, a receptor kinase expressed in most epithelial tumors, binds EphrinB2 to affect cancer cell growth, apoptosis and angiogenesis. EphB4 overexpression is associated with advanc...

Keywords:

Oncology
SEphB4-HSA
Biliary cancers
in patient
Internal medicine
first line chemotherapy
Pathology
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations